Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

When to perform hepatic resection for intermediate-stage hepatocellular carcinoma.

Cucchetti A, Djulbegovic B, Tsalatsanis A, Vitale A, Hozo I, Piscaglia F, Cescon M, Ercolani G, Tuci F, Cillo U, Pinna AD.

Hepatology. 2015 Mar;61(3):905-14. doi: 10.1002/hep.27321. Epub 2015 Jan 23.

PMID:
25048515
2.

Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.

Hsu KF, Chu CH, Chan DC, Yu JC, Shih ML, Hsieh HF, Hsieh TY, Yu CY, Hsieh CB.

Eur J Radiol. 2012 Mar;81(3):466-71. doi: 10.1016/j.ejrad.2010.12.058. Epub 2011 Mar 3.

PMID:
21376495
3.
4.

Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.

Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.

Hepatogastroenterology. 2002 Mar-Apr;49(44):518-23.

PMID:
11995486
5.

Role of surgical resection for multiple hepatocellular carcinomas.

Choi SH, Choi GH, Kim SU, Park JY, Joo DJ, Ju MK, Kim MS, Choi JS, Han KH, Kim SI.

World J Gastroenterol. 2013 Jan 21;19(3):366-74. doi: 10.3748/wjg.v19.i3.366.

6.

Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.

Ye JZ, Zhang YQ, Ye HH, Bai T, Ma L, Xiang BD, Li LQ.

World J Gastroenterol. 2014 Dec 7;20(45):17141-7. doi: 10.3748/wjg.v20.i45.17141.

7.

Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.

Guo Z, Zhong JH, Jiang JH, Zhang J, Xiang BD, Li LQ.

Ann Surg Oncol. 2014 Sep;21(9):3069-76. doi: 10.1245/s10434-014-3704-8. Epub 2014 Apr 12.

PMID:
24728740
8.

Defining optimum treatment of patients with pancreatic adenocarcinoma using regret-based decision curve analysis.

Hernandez JM, Tsalatsanis A, Humphries LA, Miladinovic B, Djulbegovic B, Velanovich V.

Ann Surg. 2014 Jun;259(6):1208-14. doi: 10.1097/SLA.0000000000000310.

PMID:
24169177
9.

Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma.

Kang JY, Choi MS, Kim SJ, Kil JS, Lee JH, Koh KC, Paik SW, Yoo BC.

Korean J Hepatol. 2010 Dec;16(4):383-8. doi: 10.3350/kjhep.2010.16.4.383.

10.

Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma.

Wei WX, Yang ZS, Lu LH, Li J, Lei ZQ, Wang K, Xia Y, Yan ZL, Shen F.

Int J Surg. 2018 Aug;56:256-263. doi: 10.1016/j.ijsu.2018.06.020. Epub 2018 Jun 20.

PMID:
29935368
11.
12.

Predictors of long-term survival in hepatocellular carcinomas: A longitudinal follow-up of 108 patients with small tumors.

Chang HC, Lin YM, Yen AM, Chen SL, Wu WY, Chiu SY, Fann JC, Lin YS, Chen HH, Liao CS.

Anticancer Res. 2013 Nov;33(11):5171-8.

PMID:
24222166
13.

Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?

Jianyong L, Lunan Y, Wentao W, Yong Z, Bo L, Tianfu W, Minqing X, Jiaying Y.

Medicine (Baltimore). 2014 Nov;93(26):e180. doi: 10.1097/MD.0000000000000180.

14.

Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E.

World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.

15.

Indications for hepatectomy for hepatocellular carcinoma - what stage of the disease is the best indication for surgery?

Sasaki Y, Imaoka S, Nakano H, Ishikawa O, Ohigashi H, Yasuda T, Nakamori S, Kameyama M, Hiratsuka M, Kabuto T, Furukawa H, Kasugai H, Inoue A, Fujita M, Inoue E.

J Hepatobiliary Pancreat Surg. 1998;5(1):14-7.

PMID:
9683748
16.

Liver resection improves the survival of patients with multiple hepatocellular carcinomas.

Ho MC, Huang GT, Tsang YM, Lee PH, Chen DS, Sheu JC, Chen CH.

Ann Surg Oncol. 2009 Apr;16(4):848-55. doi: 10.1245/s10434-008-0282-7. Epub 2009 Jan 22.

PMID:
19159983
17.

Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial.

Yoshimi F, Nagao T, Inoue S, Kawano N, Muto T, Gunji T, Ohnishi S, Imawari M.

Hepatology. 1992 Sep;16(3):702-6.

PMID:
1324216
18.

Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma.

Ochiai T, Sonoyama T, Hironaka T, Yamagishi H.

Hepatogastroenterology. 2003 May-Jun;50(51):750-5.

PMID:
12828078
19.

Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, Peng T, Xie GS, Li LQ.

Ann Surg. 2014 Aug;260(2):329-40. doi: 10.1097/SLA.0000000000000236.

PMID:
24096763
20.

Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.

Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

J Gastroenterol Hepatol. 2009 May;24(5):806-14. doi: 10.1111/j.1440-1746.2008.05728.x. Epub 2009 Jan 13.

PMID:
19207681

Supplemental Content

Support Center